Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

South Korea · Delayed Price · Currency is KRW

5,500.00

-50.00 (-0.90%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Others	7.95B	7.84B	13.84B	12.46B	9.21B
Others Growth	1.41%	-43.35%	11.05%	35.29%	5.76%
Pharmaceutical Sector	184.16B	153.26B	167.07B	163.89B	163.70B
Pharmaceutical Sector Growth	20.16%	-8.27%	1.94%	0.11%	-2.42%
Rental Sector	4.06B	3.62B	3.02B	2.93B	2.83B
Rental Sector Growth	12.03%	19.79%	3.17%	3.50%	13.03%
Adjustments and Removal	-2.23B	-2.05B	-1.22B	-1.67B	-1.92B
Total	193.94B	162.67B	182.72B	177.61B	173.83B
Total Growth	19.22%	-10.97%	2.88%	2.18%	-1.51%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	193.90B	162.59B	182.57B	177.46B	173.61B
South Korea Growth	19.25%	-10.94%	2.88%	2.22%	-1.42%
United States of America	36.28M	80.26M	151.28M	154.83M	222.08M
United States of America Growth	-54.80%	-46.95%	-2.29%	-30.28%	-43.24%
Total	193.94B	162.67B	182.72B	177.61B	173.83B
Total Growth	19.22%	-10.97%	2.88%	2.18%	-1.51%

Source: S&P Global Market Intelligence.